Neoadjuvant and adjuvant selective intraarterial regional chemotherapy in patients with pancreatic cancer
Objective. To share the experience of treatment of pancreatic cancer, using selective intraarterial regional chemotherapy (SIARCH).
Маterials and methods. Experience of treatment was presented in patients, suffering pancreatic cancer, to whom SIARCH was conducted with the objective to do a tumor restaging – preoperatively and after performing of radical and palliative operations.
Results. Surgical aspects of treatment, including complications, technique of stenting, duration of stationary treatment, the procedure faults and perspective of its application.
2. Hashimoto A, Tanaka T, Sho M, Nishiofuku H, Masada T, Sato T, et al. Adjuvant Hepatic Arterial Infusion Chemotherapy After Resection for Pancreatic Cancer Using Coaxial Catheter-Port System Compared with Conventional System. Cardiovasc InterventRadiol. 2016 Jun; 39(6):831-9. https://doi.org/10.1007/s00270-016-1292-7.
3. Nakayama A, Tajima H, Kitagawa H, Shoji M, Nakanuma S, Makino I, et al. A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer. Gan To Kagaku Ryoho. 2014 Nov; 41(12):2205-7.PMID:25731471.
4. Zheng YY, Tang CW, Xu YQ, Feng WM, Bao Y, Fei MY. Hepatic arterial infusion chemotherapy reduced hepatic metastases from pancreatic cancer after pancreatectomy. Hepatogastroenterology. 2014 Jul; 61(133):1415-20.PMID:25436319.
5. Doi T, Homma H, Akiyama T, Mezawa S, Takahashi M, Ohi M, et al. Clinical Significance of Adjuvant Surgical Resection for Initially Unresectable Pancreatic CancerResponsive to Arterial Infusion Chemotherapy. Hepatogastroenterology. 2014 May; 61(131):828-33.PMID:26176081.
This work is licensed under a Creative Commons Attribution 4.0 International License.